GSK:7
in:16
quest:2
to:20
be:3
best:5
not:3
first:2
race:3
for:8
COVID19:5
vaccine:5
Reuters:5
Discover:1
Thomson:3
ReutersFinancialGovernment:1
SolutionsLegalReuters:1
News:1
AgencyRisk:1
Management:1
SolutionsTax:1
AccountingBlog:1
Answers:1
OnInnovation:1
ReutersDirectory:1
of:17
sitesLoginContactSupportBusinessMarketsWorldPoliticsTVMoreUnited:1
States:1
Health:1
NewsJune:1
19:1
2020:2
637:1
PM:1
3:1
days:1
agoGSK:1
vaccineLudwig:1
Burger4:1
Min:1
ReadFRANKFURT:1
There:1
is:7
a:11
notable:1
name:1
missing:1
from:2
the:22
frontrunners:1
test:1
experimental:1
immunisations:1
against:4
novel:2
coronavirus:1
worlds:1
largest:1
maker:1
GlaxoSmithKline:2
GSKL:1
FILE:1
PHOTO:1
A:1
sign:1
at:1
research:1
centre:1
Stevenage:1
Britain:1
November:1
26:1
2019:1
REUTERSPeter:1
NichollsFile:1
PhotoAnd:1
that:6
absolutely:1
fine:1
according:1
British:1
groups:1
chief:1
medical:1
officer:1
vaccines:5
Thomas:1
Breuer:5
who:1
says:1
company:3
prefers:1
slow:1
and:13
steady:1
approach:1
focusing:1
on:7
an:8
established:2
technology:4
has:5
chance:1
reaching:1
widest:1
possible:1
demographic:1
Moderna:1
MRNAO:1
University:2
Oxford:1
collaboration:1
with:6
AstraZeneca:1
AZNL:1
alliance:1
BioNTech:1
BNTXO:1
Pfizer:1
PFEN:1
grabbed:1
headlines:1
by:5
moving:1
human:1
trials:1
as:4
early:1
March:1
which:2
seven:1
collaborations:2
institutions:1
or:3
firms:2
globally:1
only:1
entered:1
clinical:1
trial:1
stage:1
one:3
project:1
Friday:1
We:2
want:1
class:1
if:1
others:1
are:2
little:1
faster:1
I:1
will:2
congratulate:1
them:1
because:1
they:1
can:2
take:1
care:1
maybe:1
healthcare:1
workers:1
selected:1
countries:1
but:2
world:1
needs:1
billions:1
doses:3
we:1
contribute:2
this:1
effort:1
told:1
aims:1
socalled:1
adjuvant:5
efficacy:3
booster:1
combined:1
more:4
traditional:1
while:1
most:3
advanced:1
rival:2
projects:1
use:1
genetic:2
technologies:1
have:5
been:2
accelerated:1
through:1
preclinical:1
testing:1
labs:1
animals:1
said:4
developed:1
later:1
may:1
longer:1
better:1
especially:1
elderly:1
As:1
example:1
he:2
pointed:1
GSKs:2
bestseller:1
Shingrix:1
shingles:1
older:1
people:3
swiftly:1
replaced:1
product:1
The:2
laid:1
out:1
plans:1
May:1
produce:1
1:1
billion:1
boosters:1
shots:2
next:2
year:3
compared:1
700:1
million:1
so:1
range:2
diseases:1
it:3
usually:1
produces:1
developing:1
wide:1
partnerships:1
was:2
answer:1
minimising:1
risk:1
failure:1
allowed:1
focus:1
resources:1
its:2
promising:1
even:1
though:1
previously:1
worked:1
thing:1
offer:1
making:1
available:3
than:2
wanted:1
expose:1
our:1
several:1
goal:1
Group:1
CEO:1
Emma:1
Walmsley:1
April:1
immunisation:2
works:1
unlikely:1
emerge:1
before:1
second:1
half:1
Operation:1
Warp:1
Speed:1
US:1
push:1
develop:1
shot:1
contrast:1
wants:1
January:1
2021:1
100:1
global:1
players:1
working:1
killed:1
about:1
350000:1
It:1
contributed:1
alliances:1
involving:1
Chinese:1
biotech:1
Clover:1
Biopharmaceuticals:1
Xiamen:1
Innovax:1
Chongqing:1
Zhifei:1
300122SZ:1
well:1
Queensland:1
Australia:1
Sanofi:1
SASYPA:1
Two:1
underway:1
disclosed:1
yet:1
added:1
Reporting:1
Ludwig:1
Burger:1
Editing:1
Kirsten:1
DonovanOur:1
StandardsThe:1
Trust:1
Principles0:1
0narrowbrowserandphonemediumbrowserandportraittabletlandscapetabletmediumwidebrowserwidebrowserandlargermediumbrowserandlandscapetabletmediumwidebrowserandlargerabovephoneportraittabletandaboveaboveportraittabletlandscapetabletandabovelandscapetabletandmediumwidebrowserportraittabletandbelowlandscapetabletandbelowAppsNewslettersAdvertise:1
UsAdvertising:1
GuidelinesCookiesTerms:1
UsePrivacyAll:1
quotes:1
delayed:1
minimum:1
15:1
minutes:1
See:1
here:1
complete:1
list:1
exchanges:1
delays:1
All:1
Rights:1
Reserved:1
